Form 13-F position report

INTEGRA LIFESCIENCES HLDGS

Reported by NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO

IART 0.5 08/15/25 CUSIP 457985AM1 Manager CIK 0001141802

Reported 12,000 shares, unchanged from the prior quarter.

Reported value 0.0%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q4 2021
Shares 12,000 Quarter-end amount reported
Reported value $13,000 Fair value at quarter end
Consecutive quarters held 4 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 13000
2022-03-31 13000
2022-06-30 11000
2022-09-30 10000
2022-12-31 14543
2023-03-31 14589
2023-06-30 13695
2023-09-30 13680
2023-12-31 14085
2024-03-31 11434
2024-06-30 11298
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for INTEGRA LIFESCIENCES HLDGS held by NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -12,000 (-100.0%) 0 $0 2024-11-12
Q2 2024 Unchanged 12,000 0 (0.0%) < 0.01% $11,298 2024-08-16
Q1 2024 Reduced 12,000 -3,000 (-20.0%) < 0.01% $11,434 2024-05-15
Q4 2023 Unchanged 15,000 0 (0.0%) < 0.01% $14,085 2024-02-13
Q3 2023 Unchanged 15,000 0 (0.0%) < 0.01% $13,680 2023-11-14
Q2 2023 Unchanged 15,000 0 (0.0%) < 0.01% $13,695 2023-08-14
Q1 2023 Unchanged 15,000 0 (0.0%) < 0.01% $14,589 2023-05-15
Q4 2022 Added 15,000 +3,000 (25.0%) < 0.01% $14,543 2023-02-21
Q3 2022 Unchanged 12,000 0 (0.0%) < 0.01% $10,000 2022-11-14
Q2 2022 Unchanged 12,000 0 (0.0%) < 0.01% $11,000 2022-08-04
Q1 2022 Unchanged 12,000 0 (0.0%) < 0.01% $13,000 2022-05-09
Q4 2021 Unchanged 12,000 0 (0.0%) < 0.01% $13,000 2022-02-03
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

70 managers reported INTEGRA LIFESCIENCES HLDGS for Q4 2021.

Managers reporting INTEGRA LIFESCIENCES HLDGS in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
CANYON CAPITAL ADVISORS LLC Unchanged 60,500,000 0 2.23% $65,642,000 4 qtrs
Invesco Ltd Added 41,705,000 +17,155,000 0.01% $45,171,000 4 qtrs
HIGHBRIDGE CAPITAL MANAGEMENT LLC Added 41,248,000 +4,500,000 0.98% $45,093,000 3 qtrs
Calamos Advisors LLC Reduced 37,149 -412 0.15% $40,565,000 4 qtrs
Shaolin Capital Management LLC Added 31,605,000 +4,105,000 0.89% $34,522,000 4 qtrs
MACKAY SHIELDS LLC Reduced 26,761,000 -583,000 0.24% $29,079,000 4 qtrs
Citigroup Inc Added 25,205,000 +580,000 0.01% $27,300,000 4 qtrs
AVIVA PLC Unchanged 24,625,000 0 0.11% $26,913,000 3 qtrs
Aequim Alternative Investments LP Added 23,065,000 +9,565,000 0.78% $25,097,000 2 qtrs
JPMorgan Chase & Co Reduced 22,100,000 -327,000 < 0.01% $24,160,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 03, 2022
Filing type
13F-HR
Position type
NOTE 0.500% 8/1

Voting authority reported

Sole
0
Shared
0
None
12,000

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.